High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target
about
Structural Insights into High Density Lipoprotein: Old Models and New FactsHDL in sepsis - risk factor and therapeutic approachThe perils of surrogate endpointsComponents of Metabolic Syndrome as Risk Factors for Hearing Threshold Shifts.Gender differences in the risk factors for endothelial dysfunction in Chinese hypertensive patients: homocysteine is an independent risk factor in femalesImproving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injuryRegression of coronary atherosclerosis with infusions of the high-density lipoprotein mimetic CER-001 in patients with more extensive plaque burdenAnti-inflammatory therapies for cardiovascular diseaseRISK and SAFE signaling pathway involvement in apolipoprotein A-I-induced cardioprotectionAnti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a reviewApolipoprotein A-I mimetics.Inflammatory therapeutic targets in coronary atherosclerosis-from molecular biology to clinical application.Apolipoprotein-A1 as a damage-associated molecular patterns protein in osteoarthritis: ex vivo and in vitro pro-inflammatory propertiesRobust passive and active efflux of cellular cholesterol to a designer functional mimic of high density lipoproteinHigh-density lipoprotein attenuates Th1 and th17 autoimmune responses by modulating dendritic cell maturation and function.Serum apolipoprotein A-I and large high-density lipoprotein particles are positively correlated with FEV1 in atopic asthmaSerum levels of mitochondrial inhibitory factor 1 are independently associated with long-term prognosis in coronary artery disease: the GENES StudyMetabolic Syndrome and Associated Factors in Adults of the Amazon Region.Beta2-adrenergic activity modulates vascular tone regulation in lecithin:cholesterol acyltransferase knockout mice.Serum cholesterol levels in middle-aged euthyroid subjects with positive thyroid peroxidase antibodiesTreatment with the herbal medicine, naoxintong improves the protective effect of high-density lipoproteins on endothelial function in patients with type 2 diabetes.HDL in diabetic nephropathy has less effect in endothelial repairing than diabetes without complications.Roles of High-Density Lipoprotein Cholesterol in Patients With Acute Myocardial Infarction.Invasive coronary imaging: any role in primary and secondary prevention?The Application of a Modified d-ROMs Test for Measurement of Oxidative Stress and Oxidized High-Density Lipoprotein.High-density lipoprotein as a modulator of platelet and coagulation responses.Ethnicity and coronary artery disease: the role of high-density lipoprotein - a change in paradigm.Dysfunctional HDL and atherosclerotic cardiovascular disease.Endothelial dysfunction and vascular disease - a 30th anniversary update.HDL cholesterol: reappraisal of its clinical relevance.High-density lipoprotein reduces inflammation from cholesterol crystals by inhibiting inflammasome activation.Cardiovascular risk in patients with rheumatoid arthritis.Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease.Proinflammatory high-density lipoprotein results from oxidized lipid mediators in the pathogenesis of both idiopathic and associated types of pulmonary arterial hypertension.Vegetated land cover near residence is associated with reduced allostatic load and improved biomarkers of neuroendocrine, metabolic and immune functions.Impaired High-Density Lipoprotein Anti-Oxidative Function Is Associated With Outcome in Patients With Chronic Heart Failure.[Impact of lipid metabolism parameters on the development and progression of coronary artery disease : An update].ApoL1 levels in high density lipoprotein and cardiovascular event presentation in patients with familial hypercholesterolemia.Liver disease alters high-density lipoprotein composition, metabolism and function.Dysfunctional high-density lipoproteins have distinct composition, diminished anti-inflammatory potential and discriminate acute coronary syndrome from stable coronary artery disease patients.
P2860
Q26770434-8A8567C6-A083-437F-8867-A9D57D66277EQ26777964-D42E9CCA-BE85-4B6B-AF37-39DEF3D4D38EQ27025740-066B04DF-5010-4215-9DA7-93638264E3C8Q28385239-F3A99FD3-D577-42D9-8CA2-BDA538A8E56EQ28543526-54D26742-AB40-4470-90D1-2581237614A9Q28544407-60E3D9ED-135D-4E26-AA10-0212585F7DB8Q33714672-B2BAA785-7556-4E55-807B-CD3E97417AC3Q34137872-067D6889-EA99-4778-802A-ECC9CBEADA14Q34215871-2189E699-A529-4759-9FE2-2700B09FF731Q34238630-2B858E61-F04F-40EA-B186-A7D87CB825F3Q34421191-04152214-3305-494F-B1A5-33D58782EDF4Q34554918-9C808740-11FA-49DE-A62D-096DC3293C41Q35303738-6D23DF77-F067-4AE4-9E4A-F7A6BD35C9C9Q35536400-EAA79733-0097-42B2-81BC-8AFCFF356B8AQ35562936-2DB51AB5-2DC0-47AA-9FDC-9B824AE203D4Q35618507-BA57FC75-18C2-4D20-83D4-C337CA55EC19Q36110734-951C8CA4-4F81-477B-9D0E-18BFED172A88Q36217857-5A1F8141-83D8-4111-833C-6BB0E27F51B9Q36361831-E5737BB6-12E1-41CE-A5AF-D7F1CBA150F9Q36493221-AA0B04CF-56B4-40F1-AF82-2A835DF02BF5Q36623865-A0ADB57E-6700-4FA3-B604-F06978CCC9BFQ36796655-16A0C013-17E1-42B5-A019-4EBEA17530F5Q36891753-345701C3-D377-4AE9-BFD5-4D99A605D51DQ37030524-CFBB65FC-D105-4C4F-B6C4-0BD48ADC7563Q37691069-4B619EEB-A645-4231-B62B-D68D12ABA907Q38217201-58D7B5C2-B568-473E-BB7E-D17F2493A956Q38544542-89351ABB-A72E-4ADA-B176-0AA17B282B29Q38577283-622CB8AC-740E-43CE-83E8-970C5837940FQ38680112-86EB0AE7-6CD5-42A8-8CC9-2197902AA5E3Q38739884-09538F26-1A51-4C7B-943B-E2DFD8D0611DQ38762941-46B0B474-6226-435F-8995-EF016C9E3ED4Q38813397-BA45BF2D-EE56-4FE2-93A3-5525C81BDA24Q38853235-378C69D3-06DE-4CA7-8257-0D1016B610A0Q40178749-37B475AE-053D-41CA-AF4A-31E099099776Q40486461-2509EE68-7C40-4823-8AE1-FD11AEC7A072Q40651491-3DAD70A3-20D7-43FF-8D5D-63ABCB0DF5C0Q40740507-8486E05C-4C6F-4CEF-9B93-4DFDD9BC5981Q40782701-A0C26A62-DF51-4E5F-A054-F5836A0A49D5Q41231925-E7C6DA15-7DA7-4009-BA25-F951C1C722B2Q41260650-F15025D4-EAFD-4BEA-9988-A6CC430155F4
P2860
High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
High-density lipoprotein: vasc ...... otential as therapeutic target
@ast
High-density lipoprotein: vasc ...... otential as therapeutic target
@en
High-density lipoprotein: vasc ...... otential as therapeutic target
@nl
type
label
High-density lipoprotein: vasc ...... otential as therapeutic target
@ast
High-density lipoprotein: vasc ...... otential as therapeutic target
@en
High-density lipoprotein: vasc ...... otential as therapeutic target
@nl
prefLabel
High-density lipoprotein: vasc ...... otential as therapeutic target
@ast
High-density lipoprotein: vasc ...... otential as therapeutic target
@en
High-density lipoprotein: vasc ...... otential as therapeutic target
@nl
P3181
P1433
P1476
High-density lipoprotein: vasc ...... otential as therapeutic target
@en
P2093
Alan M. Fogelman
Thomas F. Lüscher
P304
P3181
P356
10.1161/CIRCRESAHA.114.300935
P407
P577
2014-01-03T00:00:00Z